Vicks accrued a total of 4.3 billion impressions on an estimated national TV ad spend of $18.9 million. The top network for ...

While the Trump administration remains unpredictable, some pharma experts are optimistic that the regulatory landscape will ...

Throughout 2025, AbbVie’s Skyrizi and Johnson & Johnson’s Tremfya were mainstays at the top of the monthly TV drug ad ...

The decline of linear TV, the stickiness of AI and the battle against misinformation are all on the menu for 2026.

An update from Cloudbreak Pharma, Inc. ( ($HK:2592) ) is now available. Cloudbreak Pharma has announced that its wholly owned U.S. subsidiary, ADS ...

Sun Pharmaceutical Industries Ltd. closed 4.84% short of its 52-week high of 1,850.95 rupees, which the company achieved on May 2nd.

EMA approval decision for obicetrapib and obicetrapib/ezetimibe fixed dose combo expected in 2H26 ---- Phase 3 PREVAIL CVOT overall event rate ...

The FDA is apparently not charmed by the mischievous “Lipid Lurkers” in an Esperion Therapeutics commercial for ...

Indian pharmaceutical market (IPM) has registered a growth of 8.1 percent to touch ₹2,40,672 crore in 2025 and is likely to ...

A parliamentary panel’s recent criticism of India’s drug price control mechanism has kept industry circles buzzing as the ...

TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” ...